Clinical trials are complex undertakings and whether by necessity or strategic design, an increasing number of trials are now outsourced by pharma and biotech firms. This often requires the use of multiple partners to complete all aspects of a clinical trial. Greg Guarasci (Senior Vice President, Operations and General Partner) is joined by Lara Longpre of Jennerex Biotherapeutics to consider if these multiple partnerships are the way of the future,
Explore related content and topics
Blog
Master Protocols in Clinical Trials
Master protocols are a powerful but under-utilized option for complex clinical development programs. Our Greg Licholai, MD, explores:
Resource
COVID-19 Impact on Rare Disease Clinical Trials
Rare disease patient organizations are coping with a broad range of other organizational challenges, including reduced funding, canceled fundraising…
Blog
Wearable Technology Introduces New Capabilities to Clinical Trials
Wearable devices are an essential part of our everyday lives. If you don’t own an Apple Watch or a Fitbit, chances are you know someone who does.…